Clinical Trial Update: MRI/MRSI in Risk Assessment of Prostate Cancer Patients [NA]

View source ↗

Summary

This document summarizes a completed clinical trial evaluating MRI and MR spectroscopy imaging for risk assessment in prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | NA | Status: COMPLETED